A race between SARS-CoV-2 variants and vaccination: The case of the B.1.1.7 variant in France
Abstract
The SARS-CoV-2 pandemic has entered an uncertain race between the emergence of variants that are more transmissible and vaccine roll-out. Here, we developed a mathematical model to evaluate how the interplay of variants, vaccines and non-pharmaceutical interventions might shape the pandemic dynamics, using the rise of the B.1.1.7 variant in metropolitan France as a case study. Our analysis highlights the challenges ahead for the management of the SARS-CoV-2 pandemic and shows how the quick roll-out of vaccines to at-risk individuals and non-pharmaceutical interventions are needed to mitigate the impact of the emerging variants.
Domains
Santé publique et épidémiologie
Fichier principal
Bosetti et al_Pasteur_variants and vaccination_2021.02.22.pdf (1.14 Mo)
Télécharger le fichier
Origin : Files produced by the author(s)